Health Care & Life Sciences » Pharmaceuticals | United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.37
Market Cap
HKD7.05 B
Shares Outstanding
1.64 B
Public Float
612.09 M

Profile

Address
6 Fuk Wang Street
Hong Kong
Hong Kong
Employees -
Website http://www.tul.com.cn
Updated 07/08/2019
United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA.

Financials

View All

Hoi Shan Tsoi
Chairman
Wing Hon Leung
Vice Chairman, Chief Financial Officer & Secretary